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Background

• Chemotherapy order entry, processing, preparation and administration requires
careful attention to avoid errors
• Time needed to ensure safety must be balanced with patient turnaround,
expectations and satisfaction
• Processes to facilitate timely processing and preparation
	Requirement for physician signatures 48 hours prior to patient admission or
appointment
	Development of a list of chemotherapy that can be prepared prior to
patient arrival
• Target timeframes for chemotherapy administration
	Inpatient – 120 minutes
	Outpatient – 30 minutes
The purpose of the study was to evaluate the time required for
processing, preparation and administration of pediatric chemotherapy.

Objectives
Primary objective

• Calculate the percentage of parenteral chemotherapeutic agents administered
within the target timeframe based on patient location
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Results

Conclusions

Percentage of Chemotherapy Administered Within Target Timeframe
Day One Inpatient Chemotherapy Treatment (N=33)

Outpatient Chemotherapy Treatment (N=236)
94.5%

84.8%

15.2%

5.5%
■ Met target (≤30 minutes) ■ Did not meet target

■ Met target (≤120 minutes) ■ Did not meet target

Time Required to Complete Preparation, Delivery and Chemotherapy Administration
Day 1 Inpatient
Median (IQR) N=34

Outpatient Days
Median (IQR) N=236

43 (14-55)

18 (7-29)

174 (93-254)

56 (33-83)

226 (139-297)

73.5 (53-100.5)

Pharmacy Preparation (minutes)
[Nurse release to time medication sorted]
Medication Delivery (minutes)
[Time medication sorted to medication administration]
Chemotherapy Administration (minutes)
[Nurse release to medication administration]

• Target timeframes were not consistently
met across locations and suggests
reevaluation is required
• Median pharmacy preparation times
were 43 and 18 minutes for inpatient and
outpatient days suggesting delays in
other aspects of patient management
• Orders were not signed in accordance
with current policy and eligible chemotherapy agents were not consistently
prepared prior to patient arrival
• Study evaluation did not account for
delays in patients achieving laboratory
criteria
• Gaps were identified in chemotherapy
procedures that adversely impacted
target timeframes which will need to be
addressed to improve efficiency

Secondary objectives

• Evaluate time required to complete preparation, medication delivery and
chemotherapy administration
• Calculate the percentage of eligible parenteral chemotherapy agents prepared
prior to treatment plan release
• Calculate the percentage of orders signed at least 48 hours prior to patient
appointment or admission

Methods

• Retrospective chart review performed for patients younger than 18 years that
received parenteral chemotherapy between March 1, 2019 and August 30, 2019
• Patients who received chemotherapy in the neonatal intensive care unit (NICU)
or pediatric intensive care unit (PICU) or who received investigational agents,
monoclonal antibodies, or immunotherapies as part of the chemotherapy
regimen were excluded
• Only the first dose of parenteral chemotherapy on each day was evaluated
• Median with interquartile range presented for continuous variables that were
non-normally distributed and categorical variables presented as frequencies
and percentages

Preparation of Eligible Parenteral Chemotherapy Agents Prior to Treatment
Plan Release
Cyclophosphamide

13

4

Doxorubicin

15
6
8

2
4
4

Irinotecan

23

Methotrexate

3

IT Methotrexate

91

58
2
0

70

Treatments
were not signed
prior to the
current day
of treatment*

Treatments
signed
48 hours prior
to admission/
appointment
(47.6%)

*Outpatient days, n=113; Day 1 inpatient, n=34

90

Vincristine

147

11

4

Etoposide

Vinblastine

24

8

IT Cytarabine

Ifosfamide

34

6

Cytarabine

Percentage of Orders Signed at least 48 Hours Prior to Patient Appointment
or Admission

68

0

10
20
30
40
50
60
70
■ Total Eligible Chemotherapies ■ Prepared Ahead

80

90

100

LVHN.org
© 2020 Lehigh Valley Health Network

55

Outpatient days
(48.7%)

15

Day 1 inpatient
(44.1%)

